YR6

(2Z)-2-cyano-N-[(4P)-4-(3-fluorophenyl)-5-(methanesulfonyl)pyrimidin-2-yl]-3-hydroxy-3-(5-methyl-1,2-oxazol-4-yl)prop-2-enamide

Created:	2023-02-15
Last modified:	2024-02-21

Find Related PDB Entry
2 entries where YR6 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	45
Chiral Atom Count	0
Bond Count	47
Aromatic Bond Count	17

2D diagram of YR6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2Z)-2-cyano-N-[(4P)-4-(3-fluorophenyl)-5-(methanesulfonyl)pyrimidin-2-yl]-3-hydroxy-3-(5-methyl-1,2-oxazol-4-yl)prop-2-enamide
Systematic Name (OpenEye OEToolkits)	(~{Z})-2-cyano-~{N}-[4-(3-fluorophenyl)-5-methylsulfonyl-pyrimidin-2-yl]-3-(5-methyl-1,2-oxazol-4-yl)-3-oxidanyl-prop-2-enamide
Formula	C₁₉ H₁₄ F N₅ O₅ S
Molecular Weight	443.408
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Cc1oncc1C(/O)=C(\C#N)C(=O)Nc1nc(c2cccc(F)c2)c(cn1)S(C)(=O)=O
SMILES	CACTVS	3.385	Cc1oncc1C(O)=C(C#N)C(=O)Nc2ncc(c(n2)c3cccc(F)c3)[S](C)(=O)=O
SMILES	OpenEye OEToolkits	2.0.7	Cc1c(cno1)C(=C(C#N)C(=O)Nc2ncc(c(n2)c3cccc(c3)F)S(=O)(=O)C)O
Canonical SMILES	CACTVS	3.385	Cc1oncc1\C(O)=C(/C#N)C(=O)Nc2ncc(c(n2)c3cccc(F)c3)[S](C)(=O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	Cc1c(cno1)/C(=C(\C#N)/C(=O)Nc2ncc(c(n2)c3cccc(c3)F)S(=O)(=O)C)/O
InChI	InChI	1.06	InChI=1S/C19H14FN5O5S/c1-10-14(8-23-30-10)17(26)13(7-21)18(27)25-19-22-9-15(31(2,28)29)16(24-19)11-4-3-5-12(20)6-11/h3-6,8-9,26H,1-2H3,(H,22,24,25,27)/b17-13-
InChIKey	InChI	1.06	KHDIFRJVCJOWNQ-LGMDPLHJSA-N

Related Resource References

Resource Name	Reference
PubChem	162357343

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.